Novel mechanism and molecular targeted therapy of thyroid cancer
Project/Area Number |
24591919
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General surgery
|
Research Institution | Chubu University |
Principal Investigator |
TAKEDA Kozue 中部大学, 生命健康科学部, 准教授 (80345884)
|
Co-Investigator(Kenkyū-buntansha) |
KAWAMOTO Yoshiyuki 中部大学, 生命健康科学部, 准教授 (10410664)
|
Co-Investigator(Renkei-kenkyūsha) |
KATO Masashi 名古屋大学, 医学系研究科, 教授 (10281073)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | チロシンキナーゼ / RET / がん |
Outline of Final Research Achievements |
We previously demonstrated that a specific cysteine residue is crucially involved in regulation of RET kinase activity. In this study, we successfully inhibited the oncogenic RET kinase activity through the cysteine mediated novel regulation mechanisms and suppressed the malignancy of RET expressed tumor cells.
|
Report
(4 results)
Research Products
(3 results)